13F

Stock

Atara Biotherapeutics, Inc.

ATRA · held by 41 managers

Reported value

$35.7M

Holders

41

+0 new · −0 exited

Holders’ est. mark

$82.1K

Price effect on 2 books still in the name

Largest holder

$10.4M

EcoR1 Capital, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
EcoR1 Capital, LLC573.2K$10.4MHeld
Redmile Group, LLC441.7K$7.99MHeld
Vanguard225.9K$4.09MHeld
MARSHALL WACE, LLP148.6K$2.69MHeld
GLOBEFLEX CAPITAL L P77.2K$1.4MHeld
BlackRock, Inc.67.1K$1.21MHeld
GEODE CAPITAL MANAGEMENT, LLC62.4K$1.13MHeld
MACKENZIE FINANCIAL CORP58.7K$1.05MHeld
STALEY CAPITAL ADVISERS INC50K$904.5KHeld
BRIDGEWAY CAPITAL MANAGEMENT, LLC32.7K$591.4KHeld
Renaissance Technologies30K$543.4KHeld
State Street26.5K$478.5KHeld
Quadrature Capital Ltd20.3K$367.6KHeld
Point72 Asset Management, L.P.18.3K$331KHeld
Fidelity17.2K$310.4KHeld
MORGAN STANLEY16K$289.3K$60.1KCut−$225.7K
Citadel15.6K$281.8KHeld
SUSQUEHANNA INTERNATIONAL GROUP, LLP14K$253.6KHeld
JANE STREET GROUP, LLC14K$253.1KHeld
NORTHERN TRUST CORP12.3K$223.2KHeld
Walleye Capital LLC12.2K$220.1KHeld
Connor, Clark & Lunn Investment Management Ltd.10.4K$189KHeld
BANK OF AMERICA CORP /DE/10.4K$187.9K$22KAdded$104.1K
DIMENSIONAL FUND ADVISORS LP10K$181.4KHeld
Tower Research Capital LLC (TRC)1.74K$31.4KHeld
SBI Securities Co., Ltd.1.4K$25.4KHeld
UBS Group AG1.4K$25.3KHeld
Private Wealth Asset Management, LLC900$16.3KHeld
ROYAL BANK OF CANADA850$15KHeld
JONES FINANCIAL COMPANIES LLLP703$12.7KHeld
WELLS FARGO & COMPANY/MN251$4.54KHeld
JPMORGAN CHASE & CO216$3.91KHeld
Banque Transatlantique SA176$3.18KHeld
RHUMBLINE ADVISERS175$3.17KHeld
FEDERATED HERMES, INC.130$2.35KHeld
ACADIAN ASSET MANAGEMENT LLC54K$976Held
BNP PARIBAS FINANCIAL MARKETS46$832Held
Cambridge Investment Research Advisors, Inc.22.9K$414Held
OSAIC HOLDINGS, INC.10$180Held
Rockefeller Capital Management L.P.8$145Held
KERR FINANCIAL PLANNING Corp24$112Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.